Adult B Acute Lymphoblastic Leukemia — Trials

Adult B Acute Lymphoblastic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

59 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 12
Recruiting: 3
Ph III recruiting: 0
Growth YoY: —
Industry share: 8%
Top sponsor: The First Affiliated Hospital of Soochow University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (8)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04035434	A Safety and Efficacy Study Evaluating CTX110 in Subjects With Relapsed or Refractory B-Cell Malignancies (CARBON)	terminated	Phase 1 / Phase 2	93	CRISPR Therapeutics AGINDUSTRY	6	Oct 24, 2025	clinicaltrials
NCT01408160	Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia	terminated	Phase 1	18	Albert Einstein College of MedicineOTHER	1	Sep 6, 2019	clinicaltrials